Page URL:
CONTENTS Issue #250
Happy birthday BioNews
BioNews Appeal: Please donate HERE to keep BioNews independent and FREE to read

You are currently viewing the Alert version of the BioNews email newsletter.

Click the tab above to view the Full Text version

Welcome to BioNews by email, published by the Progress Educational Trust, providing you with news, comment and reviews on genetics, assisted conception, embryo/stem cell research and related areas. 

Visit the BioNews website at where you can subscribe for free to receive BioNews by email in one of three formats, and search the archive of more than 8,000 articles.

Happy birthday BioNews
22 March 2004 - by Juliet Tizzard
Today is BioNews' fifth birthday and its 250th issue. Since we launched in 1999, the worlds of reproductive medicine, stem cell research and human genetics have given us plenty to write about. In fertility research and treatment, work to restore the fertility of cancer patients has moved on tremendously. A... [Read More]
Personalised treatment for cancer?
17 March 2004 - by BioNews
A new DNA 'chip' could pave the way for breast cancer treatments tailored to individual patients, according to French biotechnology company Ipsogen. Alane Koki, the firm's scientific director, told delegates attending the fourth European Breast Cancer Conference in Hamburg that the breast cancer profile chip (BCPC) could be available this... [Read More]
Gene clue in diabetes research
17 March 2004 - by BioNews
Two new studies have identified a link between type 2 diabetes, also known as adult-onset diabetes, and variations in a gene involved in regulating the body's glucose levels. One study, carried out by Finnish and US researchers, looked at 793 Finnish adults with the disease and compared them to 413... [Read More]
Hope for osteoporosis genetic test
17 March 2004 - by BioNews
A genetic test that identifies women at risk of developing osteoporosis could soon be available, the Daily Telegraph reports. Icelandic firm deCODE published a study last year, which suggested that certain variations in a gene called BMP2 could triple the risk of the bone-weakening disease. Now the Reykjavik-based company plans... [Read More]
Woman in baby deception faces prison
17 March 2004 - by BioNews
A woman accused of deceiving two couples into giving her money for her services as a surrogate has appeared before a UK Magistrates' Court. Moira Greenslade faces charges on three counts of obtaining money by deception and three offences under the Adoption Act. It is alleged that, while pregnant, she... [Read More]
Vatican slams fertility treatments
22 March 2004 - by BioNews
The Vatican has launched a new attack on IVF and other fertility treatments that may involve embryos being destroyed, describing them as 'a massacre of the innocents', and adding that 'no war or catastrophe has ever caused so many victims'. In the latest statement, issued by the Vatican's Pontifical Academy... [Read More]
NHS to fund 'saviour sibling' treatment
22 March 2004 - by BioNews
A second UK couple are hoping to use PGD (preimplantation genetic diagnosis) to conceive an IVF baby free from beta thalassaemia, who will also be able to provide cord blood to treat a sibling with the incurable blood disorder. The IVF treatment will carried out at the private Centre for... [Read More]
Immune cells from embryo stem cells
22 March 2004 - by BioNews
Canadian researchers have managed to turn mouse embryo stem (ES) cells into immune cells in the laboratory, a development they say could help treat cancer and HIV patients. Researchers at the University of Toronto managed to coax the ES cells to grow into 'T-cells', which normally destroy infected or cancerous... [Read More]
Genes may affect nicotine patch success
22 March 2004 - by BioNews
Women smokers with a particular genetic variation are more likely to benefit from nicotine patches when trying to quit than others, a new UK study suggests. Researchers at the University of Oxford studied 445 women and 307 men who had been heavy smokers, who were given either nicotine or control... [Read More]

Advertising in BioNews

BioNews is read by around 18,000 people every week. Our readership is predominantly in the UK, but we have subscribers in 44 countries. That is a lot of people with an interest in assisted conception, genetics, embryo/stem cell research and related areas.

Advertisements (up to 300 words in length) start from as little as £75, making BioNews a very cost effective way to reach your target audience.

The Progress Educational Trust can personally vouch for the service, as the charity has itself successfully engaged members of staff via BioNews. Why not save money by recruiting through BioNews, and help keep BioNews FREE at the same time?

If you would like further information about advertising a job or opportunity in BioNews, please contact Sarah Norcross on +44 (0)20 7278 7870 or at

Sarah Norcross
Director, Progress Educational Trust
140 Gray's Inn Road
London, WC1X 8AX